Travere Therapeutics Inc (TVTX)
18.25
-0.01
(-0.05%)
USD |
NASDAQ |
Nov 22, 16:00
18.27
+0.02
(+0.11%)
After-Hours: 20:00
Travere Therapeutics Debt to Equity Ratio: -12.43 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | -12.43 |
June 30, 2024 | 24.96 |
March 31, 2024 | 5.099 |
December 31, 2023 | 1.879 |
September 30, 2023 | 1.347 |
June 30, 2023 | 3.231 |
March 31, 2023 | 1.988 |
December 31, 2022 | 8.764 |
September 30, 2022 | 3.726 |
June 30, 2022 | 2.391 |
March 31, 2022 | 1.798 |
December 31, 2021 | 0.75 |
September 30, 2021 | 0.7278 |
June 30, 2021 | 0.6646 |
March 31, 2021 | 0.6013 |
December 31, 2020 | 1.020 |
September 30, 2020 | 0.7055 |
June 30, 2020 | 0.6591 |
March 31, 2020 | 0.9188 |
December 31, 2019 | 0.9262 |
September 30, 2019 | 0.8227 |
June 30, 2019 | 0.7214 |
Date | Value |
---|---|
March 31, 2019 | 0.77 |
December 31, 2018 | 0.6836 |
September 30, 2018 | 0.6743 |
June 30, 2018 | 0.1576 |
March 31, 2018 | 0.1511 |
December 31, 2017 | 0.1538 |
September 30, 2017 | 0.1475 |
June 30, 2017 | 0.1513 |
March 31, 2017 | 0.1481 |
December 31, 2016 | 0.1443 |
September 30, 2016 | 0.1439 |
June 30, 2016 | 0.1403 |
March 31, 2016 | 0.1376 |
December 31, 2015 | 0.1459 |
September 30, 2015 | 0.1503 |
June 30, 2015 | 0.5619 |
March 31, 2015 | 0.4998 |
December 31, 2014 | -2.249 |
September 30, 2014 | -8.176 |
June 30, 2014 | 77.62 |
March 31, 2014 | -0.8839 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-12.43
Minimum
Sep 2024
24.96
Maximum
Jun 2024
2.486
Average
1.183
Median
Debt to Equity Ratio Benchmarks
Perspective Therapeutics Inc | -- |
Electromed Inc | 0.00 |
Xtant Medical Holdings Inc | 0.7605 |
Myomo Inc | 0.00 |
Catheter Precision Inc | 0.1364 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 504.41M |
Total Liabilities (Quarterly) | 534.86M |
Shareholders Equity (Quarterly) | -30.45M |
Current Ratio | 1.709 |
Net Debt Paydown Yield | -0.04% |